Latest return on equity
Castle Biosciences Return on equity
Castle Biosciences (CSTL) return on equity with its verified observation date.
Direct answer
Castle Biosciences's return on equity is -4.2%.
The verified market snapshot reports -4.2%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 1, 2026.
Get free Castle Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -4.2%
Explore related company data
View Castle Biosciences's market capitalizationView Castle Biosciences's price-to-book ratioView Castle Biosciences's 52-week price rangeView Castle Biosciences's revenue growthView Castle Biosciences's profit marginView Castle Biosciences's debt-to-equity ratioView all Castle Biosciences key metricsReturn to Castle Biosciences profile